Levalbuterol Tartrate
Brand names: Levalbuterol Tartrate Hfa, Xopenex Hfa
At a glance
- Medicare prescriptions, 2024
- 100,837
- Medicare drug cost
- $6.4M
- Average cost per prescription
- $63.86
- Clinicians who prescribed it
- 4,705
Where it is prescribed
List the prescribers in any state, county, city or ZIP code →
What it is used for
XOPENEX HFA is a beta 2 -adrenergic agonist indicated for the treatment or prevention of bronchospasm in patients 4 years of age and older with reversible obstructive airway disease.
From the FDA-approved prescribing information (label dated June 2025). Full labels on DailyMed (opens in a new tab)
Who prescribes it
- Pulmonology 43.8%
- Nurse Practitioners 18.3%
- Family Medicine 11.0%
- Internal Medicine 10.3%
- Physician Assistants 4.8%
- Allergy & Immunology 4.2%
- Critical Care Medicine 4.0%
- General Practice 1.7%
- Sleep Medicine 0.3%
- Geriatric Medicine 0.3%
- Pediatrics 0.2%
- Hospitalist 0.2%
All prescribers, by place, name or specialty →
Share of Medicare prescriptions written by each specialty. Select one to list its prescribers.
Trend, 2019–2024
Medicare prescriptions rose 19% from 2019 to 2024.
Biggest change by state since 2019
- Florida +66%
- New York +29%
- Pennsylvania +27%
- North Carolina +21%
- Ohio +17%
- Missouri (smallest change) −18%
- California (smallest change) −14%
From CMS’s yearly state and national Part D summaries, which count every prescriber, including those CMS leaves out of its per-clinician data (fewer than 11 prescriptions). That is why these totals are higher than the count at the top of this page. Prescriptions include refills.
Industry payments about this drug
No industry payments to clinicians named this drug in 2025.
Recalls and shortages
Not on the FDA drug shortage list.
2 recalls since 2020
- Apr 2022 · McKesson Medical-Surgical Inc. Corporate Office · Class II
cGMP deviations: Temperature abuse - Mar 2021 · Cardinal Health Inc. · Class II
CGMP Deviations: Intermittent exposure to temperature excursion during storage.
Recalls usually affect specific lots from one maker, not every version of a drug. Class I is the most serious; most drug recalls are Class II. FDA recalls (opens in a new tab)
Sources: CMS Medicare Part D Prescribers by Provider and Drug (2024; prescriptions include refills, and CMS hides counts under 11 per prescriber); U.S. Food and Drug Administration, openFDA (drug labels, NDC directory, enforcement reports, drug shortages); CMS Open Payments 2025; ClinicalTrials.gov. General information only, not medical advice; not yet reviewed by our medical reviewer.